series-a
Stage
2018
Founded
1
Investors
About
Entact Bio is developing precision medicines that enhance the function of beneficial proteins using a proprietary platform called Encompass™ to create enhancement-targeting chimeric (ENTAC™) molecules, aiming to treat diseases by restoring cellular health through improved protein function.
Explore Entact Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.